Results 61 to 70 of about 48,706 (299)

The pathogenesis of mucositis : updated perspectives and emerging targets [PDF]

, 2019
Mucositis research and treatment are a rapidly evolving field providing constant new avenues of research and potential therapies. The MASCC/ISOO Mucositis Study Group regularly assesses available literature relating to pathogenesis, mechanisms, and novel
Correa, ME, Correa, M. E., Correa, M.E., Bossi, P., Bossi, P, Bateman, E, Lalla, R.V., Sonis, S, Thorpe, D, Al-Dasooqi, N., Mayo, B., Stringer, A., Al-Dasooqi, N, Sebille, Y. Van, Al-Azri, A., Wardill, H, Al-Azri, A, Bowen, J, Raber-Durlacher, J, ten Bohmer, K., Bateman, E., Bohmer, K. ten, Stringer, A, Thorpe, D., Wardill, H., Cheng, K., Sonis, S., van Sebille, Y, Lalla, RV, Bowen, J., Van Sebille, Y., Mayo, B, Lalla, R. V., Elad, S, Kandwal, A, ten Bohmer, K, Cheng, K, Kandwal, A., Elad, S., Nair, RG, Nair, R. G., Raber-Durlacher, J., Nair, R.G.   +42 more
core   +1 more source

“It's the Exact Same Treatment … Except Only 5 Min Away”: A RE‐AIM Evaluation of a Speech‐Language Pathology Shared‐Care Model for Rural Patients With Head and Neck Cancer

Head &Neck, EarlyView.
ABSTRACT Background Challenges accessing post‐treatment speech‐language pathology (SLP) services can add to treatment burden for rural patients with head and neck cancer (HNC). Hence, the aim of this study was to evaluate a shared‐care SLP service designed to support local SLP access for patients with HNC, using the RE‐AIM framework.
Corey Patterson, Elizabeth C. Ward, Rebecca L. Packer, Jasmine Foley, Laurelie R. Wishart, Clare L. Burns, Sally Pether, Wendy Comben   +7 more
wiley   +1 more source

Preventive and therapeutic assessment program for mucositis in patients with cancer: promising advances in stomatological care [PDF]

OBJECTIVES: We propose a preventive and therapeutic assessment program for mucositis in patients with cancer based on a comprehensive review of scientific evidence. MATERIAL AND METHODS: This methodological study, designed as a non-systematic
Luana Farnese Machado Abreu, Carlos Gil Moreira Ferreira, Bruno Lemos Ferrari, Daniele Ferreira Araujo, Ruan Soares da Silva, Rafaela Mota Peixoto, Tauana Batista Fernandes, Ana Maria Dias da Costa, Lourenço Duarte Siqueira, Ana Carolina de Araujo Tolentino Felizardo, Bianca Silva de Andrade, Leticia Fulgencio de Araújo, Pedro Rafael Martins De-Marchi, Renata Lemos Ferrari, Flavia Santos Dumont Sorice, Mariana Tosello Laloni, Sarah Ananda Gomes, Cristiane Decat Bergerot, Clara de Figueiredo Lopes   +18 more
core   +1 more source

New pathways for alimentary mucositis [PDF]

, 2008
Alimentary mucositis is a major dose-limiting toxicity associated with anticancer treatment. It is responsible for reducing patient quality of life and represents a significant economic burden in oncology.
Keefe, D., Bowen, J., Joanne M. Bowen, Dorothy M. K. Keefe   +3 more
core   +1 more source

Randomized Phase II Trial of Consolidation Pembrolizumab After Definitive Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma: KCSG HN19‐09, CONPELAN Study

Head &Neck, EarlyView.
ABSTRACT Background The benefit of consolidation programmed cell death protein 1 (PD‐1) blockade after chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma (NPC) remains unclear. Methods Patients with stages II–IVB NPC were randomized (2:1) to pembrolizumab 200 mg or placebo every 3 weeks for up to 17 cycles after chemoradiotherapy ...
Sang Hoon Chun, Seyoung Seo, Jang Ho Cho, Keon‐Uk Park, Sang‐Cheol Lee, Yong Won Choi, Tak Yun, Seong Hoon Shin, Sung‐Bae Kim, Seungeun Lee, Chang Ho Ahn, Bhumsuk Keam   +11 more
wiley   +1 more source

The role of mucins in mucositis [PDF]

, 2019
PURPOSE OF REVIEW: Alimentary mucositis is a severe dose limiting side effect of chemotherapy and radiotherapy. Mucin expression and secretion are associated with mucositis.
Thorpe, D.
core   +1 more source

Stereotactic Body Radiotherapy (SBRT) of Previously Unirradiated Mucosal Head and Neck Squamous Cell Carcinoma (SCC)

Head &Neck, EarlyView.
ABSTRACT Purpose To evaluate the efficacy and safety of stereotactic body radiation therapy (SBRT) in previously untreated primary mucosal head and neck cancer (HNC) patients unfit for conventional radiation therapy. Materials and Methods Retrospective analysis of previously unirradiated primary SCC mucosal HNC patients treated with SBRT from 2011 to ...
Mohammed Aldohan, Irene Karam, Amir H. Safavi, Lee Chin, Liying Zhang, Ethan Gooanratne, Madette Galapin, Antoine Eskander, Kevin Higgins, Danny Enepekides, Ian Poon   +10 more
wiley   +1 more source

Oral mucositis

National Journal of Maxillofacial Surgery, 2020
Oral mucositis is one of the most common complications of cancer therapy. It is a nonhematologic complication of cytotoxic chemotherapy and radiotherapy and reduces the quality of life. It is estimated that 40% the cases on standard chemotherapy may develop oral mucositis.
Singh, Vibha, Singh, Akhilesh Kumar
openaire   +3 more sources

Measurement Tools for Radiation‐Induced Fibrosis in Head and Neck Cancer: A Systematic Review

Head &Neck, EarlyView.
ABSTRACT Background Radiation‐induced fibrosis is a common, often debilitating late effect of head and neck cancer (HNC) treatment. An updated systematic review is needed to evaluate the reliability, validity, and clinical utility of fibrosis measurement tools.
Vanessa Helou, Pooja D. Reddy, Purva H. Rumde, Mary L. Klem, Sagar G. Kansara, Oldrich Virag, Yvonne M. Mowery, Nicole N. Scheff, Matthew E. Spector, Shaum Sridharan, Marci L. Nilsen, Kevin J. Contrera   +11 more
wiley   +1 more source

The science of mucositis [PDF]

Supportive Care in Cancer, 2022
Joanne Bowen, Hannah Wardill
openaire   +2 more sources